UltraSense

Start date
September 1, 2024
Duration
48 months
Overall budget
7M €
Number of partners
10
Contacts
Ioanna Zergioti
Coordinator
NTUA
Panagiotis Chatzis
Project Manager
AMIRES SRO

Ultra-Sound Combined with Bioelectrical Impedance Analysis and Graphene Field Effect Transistor Enhanced Wearable Sensing for Decentralised Health-Monitoring      

 

The prevalence of overweight among the European population is estimated to be near 50%, and the prevalence of obesity is around 16%. Monitoring obesity and overweight prevalence is important for assessing interventions to prevent or reduce the burden of obesity and related medical risks and providing the tools for maintaining a healthier lifestyle. UltraSense project introduces the concept of a stretchable multi-sensing platform as a wearable tool for body composition analysis and overall decentral health monitoring, fostering a sustainable and healthier lifestyle.

The platform will comprise smart features, AI signal processing and advanced stretchable materials, enabling the efficient synergy of three compartments of sensors relying on different technologies:

A. Ultra-sound compartment: delivering precise information about body composition and tissue thickness

B. Bioimpedance compartment: fast and reliable measuring of the percentage of fat, water and muscle

C. G-FET biosensor compartment: Biomarker retrieval via sweating at attomolar sensitivity in miniaturised footprint.

 

The wearable device will be validated in two use cases:

1. The effect of sport on a healthier lifestyle: monitoring the overall health of people who exercise

2. Early detection and continuous monitoring of metabolic syndrome.

 

Ultra-Sense’s data will be displayed to the user consistently and reliably so that medical advice can be sought. The project’s green and circular material synthesis approaches will reduce the related CO2 emissions by more than 70% from solvent processing. UltraSense will have a substantial societal and economic impact: 700k devices will be sold annually by 2032 for 105M€ of revenues, reaching a 10% market share and associated with 20 new jobs. Millions of people will have access to low-cost, easy-to-use devices that inform them of their body composition, help them improve their lifestyle, reduce obesity and metabolic diseases, and reduce related treatment costs.

 

AMIRES was involved in the project’s preparatory phase and negotiations. AMIRES is leading Communication, Dissemination, and Exploitation activities and supporting the coordinator in Project Management.

 

  • Partners:
    • NATIONAL TECHNICAL UNIVERSITY OF ATHENS
    • POLAR ELECTRO OY
    • VTT TECHNICAL RESEARCH CENTRE OY
    • GRAPHENEA SEMICONDUCTOR SL
    • XTPL SPOLKA AKCYJNA
    • UNIVERSITAT POLITECNICA DE VALENCIA
    • UNIVERSITY of OULU
    • INSTITUT JOZEF STEFAN
    • AMIRES SRO
    • BETTHERA SRO

 

This project has received funding from the European Union’s Horizon Europe Research and Innovation Programme under grant agreement No 101130192, project UltraSense.